35 - FLT-PET to evaluate sequencing of chemotherapies to enhance efficacy of treatment in triple negative breast cancers (ID 15) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

35 - FLT-PET to evaluate sequencing of chemotherapies to enhance efficacy of treatment in triple negative breast cancers (ID 15)

Oncology: Basic & Translational -> Image-Guided 35

35 - FLT-PET to evaluate sequencing of chemotherapies to enhance efficacy of treatment in triple negative breast cancers (ID 15)

Session Name

Center for Therapy Excellence YIA Symposium

Speakers

Y. Lu

Authors

Presentation Topic

Oncology: Basic & Translational -> Image-Guided

Presentation Number

35

Previous Eposter

34 - Self-Assembling and DisAssembling Bispecific Antibodies for Curative 2-step Pretargeted Radioimmunotherapy (ID 13)

Next Eposters

36 - Low-dose TRT reshapes the microenvironment of prostate tumors to potentiate response to immunotherapy (ID 14)

37 - Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer (ID 1231)

38 - Diagnostic Performance of PSMA-Targeted ¹⁸F-DCFPyL PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the Phase 3, Multicenter CONDOR Study (ID 1227)

39 - Survey by the French Medicine Agency (ANSM) of the practice, result and impact of ⁶⁸Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer with non-contributive ¹⁸F-fluorocholine PET/CT: 1177 examinations (ID 1234)

40 - Preliminary results of a prospective, multicenter trial assessing the impact of ¹⁸F-DCFPyL-PET/CT on the management of patients with recurrent prostate cancer. (ID 1228)

41 - Incidence of local prostate cancer recurrence by 68Ga-PSMA-11 PET/CT is higher after definitive Radiation Therapy than after Radical Prostatectomy: a single center post-hoc retrospective analysis of recurrence patterns of 787 patients. (ID 1233)

42 - Matched-pair comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrent prostate cancer (ID 1229)

43 - Impact of⁶⁸Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial (ID 1232)

44 - Combined value of PSMA-based 18F-DCFPyL, 18F-FDG and 18F-NaF PET/CT imaging in metastatic prostate cancer patients (ID 1230)

45 - The effect of changes of serum thyrotropin receptor antibody on the outcome of radioactive iodide therapy for Graves’ hyperthyroidism (ID 283)